Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tranexamic acid (cyklokapron) (1 trial)
gabapentin (neurontin) (1 trial)
Blood Loss, Surgical (Phase 4)
Femoral Fractures (Phase 4)
Fibromyalgia (Phase 3)
Fractures, Bone (Phase 4)
Hemorrhage (Phase 4)
Hip Fractures (Phase 4)
Myofascial Pain Syndromes (Phase 3)
Trials (2 total)
Trial APIs (2 total)